scispace - formally typeset
J

Jennie Ponsford

Researcher at Monash University, Clayton campus

Publications -  443
Citations -  21759

Jennie Ponsford is an academic researcher from Monash University, Clayton campus. The author has contributed to research in topics: Traumatic brain injury & Poison control. The author has an hindex of 73, co-authored 393 publications receiving 18379 citations. Previous affiliations of Jennie Ponsford include Monash University & Maastricht University.

Papers
More filters
Journal ArticleDOI

Supporting children and young people with an acquired brain injury (ABI) and their siblings: The experience of a camp for families with a child with an ABI

TL;DR: Camps appear to offer opportunities to enjoy typical childhood experiences while restoring a sense of security, increasing understanding of ABI and validating attendees’ experiences, and may, therefore, offer low-cost interventions to support children with ABI
Journal ArticleDOI

The Association Between Fault Attribution and Work Participation After Road Traffic Injury: A Registry-Based Observational Study

TL;DR: Targeted interventions are needed to support work participation in people at risk of poor RTW post-injury and interventions targeting fault and justice-related attributions are currently lacking, these may be beneficial for people who believe that another caused their injury.
Journal ArticleDOI

Pharmacotherapy for the pseudobulbar affect in individuals who have sustained a traumatic brain injury: a systematic review protocol.

TL;DR: This systematic review is to synthesize current evidence on the effectiveness of pharmacotherapy as compared to all comparators for the management of pseudobulbar affect in adults 16 years and over who have sustained a traumatic brain injury.
Journal ArticleDOI

Efficacy and Harms of Pharmacological Interventions for Anxiety after Traumatic Brain Injury: Systematic Review

TL;DR: There is a critical need for adequately powered and controlled studies of pharmacological interventions for anxiety following TBI across all severities that examine side effect profiles, and consider issues of comorbidity and effects of long-term pharmacotherapy.